Breast Cancer Tumor Care Observational Programme

AstraZeneca

Status: Completed

Conditions: Arthralgia; Post Menopausal

Treatments: Drug: anastrozole

Study type: Observational

Funder types: Industry

Identifiers

NCT00660244

NIS-OAT-ARI-2007/1

Details and patient eligibility

About

The purpose of this study is to investigate efficacy and tolerability under anastrozole (Arimidex) treatment.

Enrollment: 150 patients

Sex: Female

Volunteers: No Healthy Volunteers

Inclusion criteria

• Postmenopausal women
• Already on upfront Arimidex Therapy (Start 1-4 weeks before)
• HR+

Exclusion criteria

• Premenopausal women
• Tamoxifen switch patients

Trial design

150 participants in 1 patient group

1

Treatment:

Drug: anastrozole